AP-011

N/A

Report date: 2025/01/26 18:39:27

Base Information

Drug NameAP-011
Drug Alias Namealecmestencel-Lallogenic mesenchymal cell therapy (Apceth)AP-011
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApceth Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesApceth Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A